Reversine attenuates cholestatic ductular reaction in rats. 2023

Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
Department of Surgery, Guangzhou First People's Hospital, Guangzhou, China.

Ductular reaction (DR) is usually observed in biliary disorders or various liver disorders, including nonalcoholic fatty liver disease. Few studies have focused on interrupting the DR process in the cholestatic environment. Here, we investigated the impact of reversine on DR in rats that had undergone bile duct ligation (BDL). Cholestatic injury was induced in rats 2 weeks following BDL. DR was assessed with biliary markers by immunohistochemistry. Biliary epithelial cells (BECs) were isolated for the analysis of proliferation and biliary factor gene expression. The effects of reversine on DR and fibrosis were analyzed in vivo via intraperitoneal injection in rats for 2 weeks. Chemically-induced BEC formation was used to investigate the biliary markers affected by reversine in vitro. DR with increased BEC expansion was identified in cholestatic liver injury, as indicated by CK7, CK19, and EpCAM expression around the portal vein in BDL rats. BDL-induced DR cells showed the increased expression of genes regulating cell proliferation (Ki67, Foxm1, and Pcna) and biliary markers (Krt7, Krt19, Epcam, Sox9, Cftr, and Asbt). Reversine attenuated cholestatic fibrosis and DR in rats. Reversine affected chemically-induced BEC formation, with the decreased expression of biliary Krt7, Cftr, and Ggt1 genes in vitro. BDL-induced Notch activation was attenuated upon reversine treatment in vivo, in part via the Notch/Sox9 pathway. In conclusion, reversine attenuated cholestatic ductular reaction and fibrosis in rats and reduced the bile duct formation associated with Dlk1/Notch/Sox9 signaling. Reversine may be regarded as a potential drug for cholangiopathies for preventing a ductular reaction.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D000071858 Epithelial Cell Adhesion Molecule A cell adhesion molecule that is expressed on the membranes of nearly all EPITHELIAL CELLS, especially at the junctions between intestinal epithelial cells and intraepithelial LYMPHOCYTES. It also is expressed on the surface of ADENOCARCINOMA and epithelial tumor cells. It may function in the MUCOSA through homophilic interactions to provide a barrier against infection. It also regulates the proliferation and differentiation of EMBRYONIC STEM CELLS. Antigen, CD326,CD326 Protein,ESA Antigen,Ep-CAM,EpCAM,Epithelial Specific Antigen,GA 733 Tumor-Associated Antigen,GA733 Antigen,GA733 Tumor-Associated Antigen,Tacstd1 Protein,Tumor-Associated Antigen GA733,Antigen, ESA,Antigen, Epithelial Specific,Antigen, GA733,CD326 Antigen,GA 733 Tumor Associated Antigen,GA733 Tumor Associated Antigen,GA733, Tumor-Associated Antigen,Tumor Associated Antigen GA733,Tumor-Associated Antigen, GA733
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019005 Cystic Fibrosis Transmembrane Conductance Regulator A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. (Hum Genet 1994;93(4):364-8) CFTR Protein,Chloride channels, ATP-gated CFTR,Chloride channels, ATP gated CFTR,Protein, CFTR
D036341 Intercellular Signaling Peptides and Proteins Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal. Growth Factor,Growth Factors,Paracrine Peptide Factors,Paracrine Protein Factors,Factor, Growth,Factors, Growth,Peptide Factors, Paracrine

Related Publications

Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
March 2024, The American journal of pathology,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
April 2022, Bulletin of experimental biology and medicine,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
January 2017, The American journal of pathology,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
January 2020, Gastroenterologia y hepatologia,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
July 2023, Journal of traditional and complementary medicine,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
November 2015, The Journal of pathology,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
July 1995, Pathology, research and practice,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
May 2016, Liver international : official journal of the International Association for the Study of the Liver,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
March 2023, Stem cell research & therapy,
Di Huang, and Lijuan Tang, and Tianyang Li, and Peilin Li, and Zisheng Huang, and Jiefeng Weng, and Shuai Zhang, and Weili Gu, and Yu Huang
December 2002, Journal of Korean medical science,
Copied contents to your clipboard!